Cardiology Department, Bern University Hospital, Switzerland.
Eur J Histochem. 2012 Apr 16;56(2):e15. doi: 10.4081/ejh.2012.15.
Sodium nitroprusside (SNP) is used clinically as a rapid-acting vasodilator and in experimental models as donor of nitric oxide (NO). High concentrations of NO have been reported to induce cardiotoxic effects including apoptosis by the formation of reactive oxygen species. We have therefore investigated effects of SNP on the myofibrillar cytoskeleton, contractility and cell death in long-term cultured adult rat cardiomyocytes at different time points after treatment. Our results show, that SNP treatment at first results in a gradual increase of cytoskeleton degradation marked by the loss of actin labeling and fragmentation of sarcomeric structure, followed by the appearance of TUNEL-positive nuclei. Already lower doses of SNP decreased contractility of cardiomyocytes paced at 2 Hz without changes of intracellular calcium concentration. Ultrastructural analysis of the cultured cells demonstrated mitochondrial changes and disintegration of sarcomeric alignment. These adverse effects of SNP in cardiomyocytes were reminiscent of anthracycline-induced cardiotoxicity, which also involves a dysregulation of NO with the consequence of myofibrillar degradation and ultimately cell death. An inhibition of the pathways leading to the generation of reactive NO products, or their neutralization, may be of significant therapeutic benefit for both SNP and anthracycline-induced cardiotoxicity.
硝普钠(SNP)在临床上被用作一种快速作用的血管扩张剂,在实验模型中作为一氧化氮(NO)的供体。据报道,高浓度的 NO 通过形成活性氧物种引起心脏毒性作用,包括细胞凋亡。因此,我们研究了 SNP 在不同处理时间后对长期培养的成年大鼠心肌细胞的肌原纤维细胞骨架、收缩性和细胞死亡的影响。我们的结果表明,SNP 处理首先导致细胞骨架降解逐渐增加,表现为肌动蛋白标记物丢失和肌节结构碎片化,随后出现 TUNEL 阳性核。即使较低剂量的 SNP 也会降低以 2 Hz 起搏的心肌细胞的收缩性,而细胞内钙浓度没有变化。培养细胞的超微结构分析显示线粒体变化和肌节排列解体。SNP 在心肌细胞中的这些不良作用类似于蒽环类药物引起的心脏毒性,这也涉及到 NO 的失调,导致肌原纤维降解,最终导致细胞死亡。抑制导致产生活性 NO 产物的途径或中和这些产物可能对 SNP 和蒽环类药物引起的心脏毒性都具有重要的治疗益处。